| 19/04/2024 |
08:00 to 09:15 |
Golden Hall |
Bladder Module - Localized Disease Session |
08:00 to 08:20 |
Urinary markers in the diagnosis and follow-up of non-muscle-invasive bladder cancer |
Speaker |
| 19/04/2024 |
08:00 to 09:15 |
Golden Hall |
Bladder Module - Localized Disease Session |
08:20 to 08:25 |
Discussion |
Discussant |
| 19/04/2024 |
08:00 to 09:15 |
Golden Hall |
Bladder Module - Localized Disease Session |
08:50 to 09:10 |
TURB and RE-TURB in 2024: time to change and improve our clinical practice |
Speaker |
| 19/04/2024 |
08:00 to 09:15 |
Golden Hall |
Bladder Module - Localized Disease Session |
09:10 to 09:15 |
Discussion |
Discussant |
| 19/04/2024 |
09:15 to 09:55 |
Golden Hall |
Clinical cases: bladder cancer - non-muscle-invasive disease |
|
|
Discussant |
| 19/04/2024 |
10:15 to 11:55 |
Golden Hall |
Bladder Module - Localized Disease Session |
10:15 to 10:35 |
Robotic surgery and urinary tracts: which is ideal for each patient? |
Speaker |
| 19/04/2024 |
10:15 to 11:55 |
Golden Hall |
Bladder Module - Localized Disease Session |
10:35 to 10:40 |
Discussion |
Discussant |
| 19/04/2024 |
10:15 to 11:55 |
Golden Hall |
Bladder Module - Localized Disease Session |
11:05 to 11:25 |
Lymphadenectomy for muscle-invasive bladder cancer: how to proceed? |
Speaker |
| 19/04/2024 |
10:15 to 11:55 |
Golden Hall |
Bladder Module - Localized Disease Session |
11:25 to 11:30 |
Discussion |
Discussant |
| 19/04/2024 |
12:05 to 12:45 |
Golden Hall |
Clinical cases: bladder cancer - muscle-invasive disease |
|
|
Discussant |
